Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of a Cochlear Implant Sound Processor

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
General Inclusion Criteria:~* Ability to provide Informed Consent~* 18 years of age or older~* Unilateral user of a HiResolutionTM Bionic Ear System (HiRes 90KTM, HiRes 90KTM Advantage, HiResTM Ultra, HiResTM Ultra 3D), including bilaterally implanted subjects that only use one implant in their everyday listening modality~* Minimum of 6 months of CI experience~* Having used a Naída CI Q70 or a Naída CI Q90 as their primary processor for a minimum of one month~* Presently using a current steering strategy~* At least moderate open-set speech recognition abilities with implant alone, as defined by achieving a score of ≥ 60% words correct in the AzBio in quiet test using the Naída CI Q90 research processor~* English language proficiency as determined by the investigator~* Willingness to use a BTE processor for the duration of the study~ARH Arm Inclusion Criteria~* Residual low frequency hearing sensitivity (pure tone average of \< 70 dB HL for 125, 250, and 500 Hz) and a severe-to-profound high-frequency sensorineural hearing loss (pure tone average of ≥ 70 dB HL for 1,000, 2,000, 3000, 4,000, and 8,000 Hz) in the implanted ear~* Willingness to use an in-canal acoustic earhook for the duration of the study~EO Arm Inclusion Criteria~• Severe-to-profound sensorineural hearing loss in the low (pure tone average of ≥ 70 dB HL for 125, 250, and 500 Hz) and high frequencies (pure tone average ≥ 70 dB HL for 1,000, 2,000, 3000, 4,000, and 8,000 Hz) in the implanted ear~Exclusion Criteria:~* Unrealistic expectations regarding potential benefits, risks and limitations of the investigational device as determined by the investigator~* Unwillingness or physical / cognitive inability of subject to comply with all investigational requirements as determined by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aidable Residual Hearing (ARH) Cohort (Type: OTHER): Control Device followed by experimental Device.
- Electric Only (EO) Cohort (Type: OTHER): Control Device followed by experimental Device.

Based on this trial design, predict the completion outcome and termination type (if applicable).